Skip to main content
SpringerLink
Log in

Mycobacterium ulcerans Infection

  • Chapter
  • First Online:
Mycobacterial Skin Infections

  • 823 Accesses

Abstract

Mycobacterium ulcerans is the causative agent of a new emerging infectious disease, which has been reported in at least 33 countries worldwide with tropical, subtropical and temperate climates (Table 10.1) [1–8].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 179.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Pradinaud R, Couppié P, Versapuech J (2003) Mycobactérioses cutanées environmentales dont l’infection à Mycobacterium ulcerans (“ulcère de Buruli”). Encycl Méd Chir (Editions Scientifiques et Médicales Elsevier SAS, Paris), Maladies Infectieuses, 8-038-F-15

    Google Scholar 

  2. van der Werf TS, van der Graaf WTA, Tappero JW et al (1999) Mycobacterium ulcerans infection. Lancet 354:1013

    Google Scholar 

  3. Centers for Disease Control and Prevention (CDC) (2015) Buruli ulcer. https://www.cdc.gov/buruli-ulcer

  4. Sizaire V, Nackers F, Comte E et al (2006) Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis 6:288

    Article  PubMed  Google Scholar 

  5. Sears AV, Hay RJ (2015) Buruli ulcer—a rapidly changing scene. Acta Derm Venereol 95:387

    Article  PubMed  Google Scholar 

  6. Yotsu RR, Murase C, Sugawara M et al (2015) Revisiting Buruli ulcer. J Dermatol 42:1033

    Article  PubMed  Google Scholar 

  7. World Health Organization (2015) Buruli ulcer (Mycobacterium ulcerans infection). http://www.who.int/mediacentre/factsheets/fs199/en/updatedfebruary2015

  8. World Health Organization (2016) Buruli ulcer (Mycobacterium ulcerans infection). http://www.who.int/mediacentre/factsheets/fs199/en/updatedfebruary2016

  9. Merritt RW, Walker ED, Small PL et al (2010) Ecology and transmission of Buruli ulcer disease: a systematic review. PLoS Negl Trop Dis 4:e911

    Article  PubMed Central  PubMed  Google Scholar 

  10. World Health Organization (2013) Buruli ulcer (Mycobacterium ulcerans infection). Fact sheet No 199. Retrivied 23 Feb 2014

    Google Scholar 

  11. Nakanaga K, Yotsu RR, Hoshino Y et al (2013) Buruli ulcer and mycolactone-producing mycobacteria. Jpn J Infect Dis 66:83

    Article  PubMed  Google Scholar 

  12. MacCallum P, Tolhurst JC, Buckle G et al (1948) A new mycobacterial infection in man. J Pathol Bacteriol 60:93

    Article  CAS  PubMed  Google Scholar 

  13. Buckle G, Tolhurst JC (1948) A new mycobacterial infection in man; cultivation of the new mycobacterial infection in man; cultivation of the new mycobacterium. J Pathol Bacteriol 60:116

    CAS  PubMed  Google Scholar 

  14. van Oye E, Ballion M (1950) Is it necessary to take into account a new infection from acid-resistant bacilli in Africa? Preliminary note. Ann Soc Belg Med Trop 30:619

    Google Scholar 

  15. Meyers WM, Shelly WM, Connor DH et al (1974) Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg 23:919

    Article  CAS  PubMed  Google Scholar 

  16. Clancey JK, Dodge OG, Lunn HF et al (1961) Mycobacterial skin ulcers in Uganda. Lancet 2:951

    Article  CAS  PubMed  Google Scholar 

  17. Anonymous (1970) Buruli ulcer. Br Med J 2:378

    Google Scholar 

  18. Gray HH, Kingma S, Kok SH (1967) Mycobacterial skin ulcers in Nigeria. Trans R Soc Trop Med Hyg 61:712

    Article  CAS  PubMed  Google Scholar 

  19. Oluwasanmi JO, Solankee TF, Olurin EO et al (1976) Mycobacterium ulcerans (Buruli) skin ulceration in Nigeria. Am J Trop Med Hyg 25:122

    Article  CAS  PubMed  Google Scholar 

  20. Ouoba K, Sano D, Traoré A et al (1998) Buruli ulcers in Burkina Faso: apropos of 6 cases. Tunis Med 76:46

    CAS  PubMed  Google Scholar 

  21. van der Werf TS, van der Graaf WT, Groothuis DG et al (1989) Mycobacterium ulcerans infection in Ashanti region, Ghana. Trans R Soc Trop Med Hyg 83:410

    Article  PubMed  Google Scholar 

  22. Marston BJ, Diallo MO, Horsburgh CR Jr et al (1995) Emergence of Buruli ulcer disease in the Daloa region of Côte d’Ivoire. Am J Trop Med Hyg 52:219

    Article  CAS  PubMed  Google Scholar 

  23. Aguiar J, Steunou C (1997) Buruli ulcers in rural areas of Benin: management of 635 cases. Med Trop (Mars) 57:83

    CAS  Google Scholar 

  24. Bessis D, Kempf M, Marsollier L (2015) Mycobacterium ulcerans disease (Buruli ulcer) in Mali: a new potential African endemic country. Acta Derm Venereol 95:489

    Article  PubMed  Google Scholar 

  25. Ezzedine K, Pistone T, Guir V et al (2010) Painful Buruli ulcer in a Malian visitor to France. Acta Derm Venereol 90:424

    Article  PubMed  Google Scholar 

  26. Kanga JM, Kacou ED (2001) Epidemiological aspects of Buruli ulcer in Côte d’Ivoire: results of a national survey. Bull Soc Pathol Exot 94:46

    CAS  PubMed  Google Scholar 

  27. Faber WR, Arias-Bouda LM, Zeegelaar JE et al (2000) First reported case of Mycobacterium ulcerans infection in a patient from China. Trans R Soc Trop Med Hyg 94:277

    Article  CAS  PubMed  Google Scholar 

  28. Nakanaga K, Hoshino Y, Yotsu RR et al (2011) Nineteen cases of Buruli ulcer diagnosed in Japan from 1980 to 2010. J Clin Microbiol 49:3829

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  29. Yotsou RR, Nakanaga K, Hoshino Y et al (2012) Buruli ulcer and current situation in Japan: a new emerging cutaneous Mycobacterium infection. J Dermatol 39:587

    Article  CAS  Google Scholar 

  30. Aguilar PL, Iturribarria FM, Middlebrook G (1953) A case of human infection by Mycobacterium ulcerans in the western hemisphere; preliminary note. Int J Lepr 21:469

    CAS  PubMed  Google Scholar 

  31. Guerra H, Palomino JC, Falconí E et al (2008) Mycobacterium ulcerans disease, Peru. Emerg Infect Dis 14:373

    Article  PubMed Central  PubMed  Google Scholar 

  32. Soldaña-Patiño J (1988) First findings of Buruli ulcer in Peru. Acta Med Hosp Militar Central 5:55

    Google Scholar 

  33. dos Santos VM, Noronha FL, Vicentina EC et al (2007) Mycobacterium ulcerans infection in Brazil. Med J Aust 187:63

    PubMed  Google Scholar 

  34. Pradinaud R, Basset A, Grosshans E (1974) Vingt cas de mycobactérioses cutaneés en Guyane Française. Castellania 2:273

    Google Scholar 

  35. Prévot G, Marsallier L, Carbonelle B et al (2004) Diagnostic de l’infection à Mycobacterium ulcerans en Guyane Française. Presse Méd 33:1520

    Article  Google Scholar 

  36. Radforf AJ (1974) Mycobacterium ulcerans: a review. I. Epidemiology. Papua New Guinea Med J 17:129

    Google Scholar 

  37. Flood P, Street A, O’Brien P et al (1994) Mycobacterium ulcerans infection on Phillip Island, Victoria. Med J Aust 160:160

    CAS  PubMed  Google Scholar 

  38. Hayman J (1984) Mycobacterium ulcerans: an infection from Jurassic time? Lancet 2:1015

    Google Scholar 

  39. Pradinaud R (2005) The mycobacterium infection cannot be called “Buruli ulcer” any longer. Bull Soc Pathol Exot 98:26

    CAS  PubMed  Google Scholar 

  40. Pradinaud R (2007) L’infection à Mycobacterium ulcerans ne doit plus être restreinte à l’impropre appellation “ulcère de Buruli”. Ann Dermatol Venereol 134:1523

    Article  Google Scholar 

  41. Buruli ulcer (2017) Wikipedia https://it.wikipedia.org/wiki/Ulcera_del_Buruli

  42. Meyers DH (2007) Mycobacterium ulcerans infection: an eponymous ulcer (Letter). Med J Aust 187:63

    PubMed  Google Scholar 

  43. Alsop D (1972) The Bairnsdale ulcer. Aust N Z J Surg 41:317

    CAS  PubMed  Google Scholar 

  44. Johnson PDR, Hayman JA (2007) Comment to the letter of Meyers: reference No 42. Med J Aust 187:63

    Google Scholar 

  45. World Health Organization. Buruli ulcer. Global Buruli ulcer initiative (2017). http://www.who.int/buruli/en/

  46. Johnson DPR, Hayman JA, Quck TY et al (2007) Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust 184:64.s

    Google Scholar 

  47. Chemlal K, De Ridder K, Fonteyne PA et al (2001) The use of IS2404 restriction fragment length polymorphisms suggests the diversity of Mycobacterium ulcerans from different geographical areas. Am J Trop Med Hyg 64:270

    Article  CAS  PubMed  Google Scholar 

  48. Stienstra Y, van der Graaf WT, Asamoa K et al (2002) Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg 67:207

    Article  PubMed  Google Scholar 

  49. Aujoulat I, Johnson C, Zinsou C et al (2003) Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin. Tropical Med Int Health 8:750

    Article  Google Scholar 

  50. Debacker M, Aguiar J, Steunou C et al (2004) Mycobacterium ulcerans disease (Buruli ulcer) in rural hospital, Southern Benin, 1997–2001. Emerg Infect Dis 10:1391

    Article  PubMed Central  PubMed  Google Scholar 

  51. World Health Organization (2002) Buruli ulcer disease. Mycobacterium ulcerans infection. Wkly Epidemiol Rec 77:271

    Google Scholar 

  52. Qi W, Käser M, Röltgen K et al. Genomic diversity and evolution of Mycobacterium ulcerans revealed by next-generation sequencing. PLoS Pathog 2009;5:e1000580.

    Google Scholar 

  53. Ortiz RH, Leon DA, Estevez HO et al (2009) Differences in virulence and immune response induced in a murine model by isolates of Mycobacterium ulcerans from different geographic areas. Clin Exp Immunol:157–271

    Google Scholar 

  54. World Health Organization (2015) Global Health Observatory (GHO) data: Buruli ulcer. http://www.who.int/gho/regkected.diseases/buruli_ulcer/en-. Accessed 4 Apr 2015

  55. Debacker M, Aguiar J, Steunou C et al (2004) Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Tropical Med Int Health 9:1297

    Article  CAS  Google Scholar 

  56. Quek TY, Athan E, Henry MJ et al (2007) Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis 13:1661

    Article  PubMed Central  PubMed  Google Scholar 

  57. Coloma JN, Navarrete-Franco G, Iribe P et al (2005) Ulcerative cutaneous mycobacteriosis due to Mycobacterium ulcerans: report of two Mexican cases. Int J Lepr Other Mycobact Dis 73:5

    Article  PubMed  Google Scholar 

  58. McGann H, Stragier P, Portaels F et al (2009) Buruli ulcer in United Kingdom tourist returning from Latin America. Emerg Infect Dis 15:1827

    Article  PubMed Central  PubMed  Google Scholar 

  59. Portaels F, Debacker M, Anyo G et al (2008) Buruli ulcer is an imported and exported disease. WHO Annual meeting on Buruli ulcer: March 31–2 April 2008 Abstracts, The Organization, Geneva, p 125

    Google Scholar 

  60. World Health Organization (2004) Buruli ulcer disease. Mycobacterium ulcerans infection. Corrigendum to No 15, 2004, Weekly Epidem Record, No 20, p 194

    Google Scholar 

  61. Exner K, Lemperle G (1987) Buruli ulcer—necrotizing infection of the hand of a plastic surgeon. Handchir Mikrochir Plast Chir 19:230

    CAS  PubMed  Google Scholar 

  62. Weitzul S, Eichhorn PJ, Pandya AG (2000) Nontuberculous mycobacterial infections of the skin. Dermatol Clin 18:359

    Article  CAS  PubMed  Google Scholar 

  63. Griffith DE, Aksamit T, Brown-Elliott BA et al (2007) An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 175:367

    Article  CAS  PubMed  Google Scholar 

  64. Bonamonte D, Filoni A, Vestita M et al (2016) Cutaneous infection from aquatic environments. In: Bonamonte D, Angelini G (eds) Aquatic dermatology. Biotic, chemical and physical agents. Springer Verlag, Berlin, p 185

    Chapter  Google Scholar 

  65. Palomino JC, Portaels F (1998) Effects of decontamination methods and culture conditions on viability of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 36:402

    CAS  PubMed Central  PubMed  Google Scholar 

  66. Portaels F, Agular J, Fissette K et al (1997) Direct detection and identification of Mycobacterium ulcerans in clinical specimens by PCR and oligonucleotide-specific capture plate hybridization. J Clin Microbiol 35:1097

    CAS  PubMed Central  PubMed  Google Scholar 

  67. Portaels F, Elsen P, Guimaraes-Peres A et al (1999) Insects in the transmission of Mycobacterium ulcerans infection. Lancet 353:986

    Article  CAS  PubMed  Google Scholar 

  68. Mve-Obiang A, Lee RE, Umstot ES et al (2005) A newly discovered mycobacterial pathogen isolated from laboratory colonies of Xenopus species with lethal infections produces a novel form of mycolactone, the Mycobacterium ulcerans macrolide toxin. Infect Immun 73:3307

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  69. Rhodes MW, Kator H, McNabb A et al (2005) Mycobacterium pseudoshottsii sp. nov., a slowly growing chromogenic species isolated from Chesapeake Bay striped bass (Morone saxatilis). Int J Syst Evol Microbiol 55:1139

    Article  CAS  PubMed  Google Scholar 

  70. Ranger BS, Mahrous EA, Mosi L et al (2006) Globally distributed mycobacterial fish pathogens produce a novel plasmid-encoded toxic macrolide, mycolactone F. Infect Immun 74:6037

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  71. Käser M, Hauser J, Small P et al (2009) Large sequence polymorphisms unveil the phylogenetic relationship of environmental and pathogenic mycobacteria related to Mycobacterium ulcerans. Appl Environ Microbiol 75:5667

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  72. Stinear TP, Seemann T, Pidot S et al (2007) Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res 17:192

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  73. Stinear TP, Johnson PDR (2007) From marinum to ulcerans: a mycobacterial human pathogen emerges. Microbe 2:187

    Google Scholar 

  74. Demangel C, Stinear TP, Cole ST (2009) Buruli ulcer: reductive evolution enhances pathogenicity of Mycobacterium ulcerans. Nat Rev Microbiol 7:50

    Article  CAS  PubMed  Google Scholar 

  75. Stinear TP, Seemann T, Harrison PF et al (2008) Insights from the complete genome sequence of Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 18:729

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  76. Stinear TP, Mve-Obiang A, Small PL et al (2004) Giant plasmid-encoded polyketide synthases produce the macrolide toxin of Mycobacterium ulcerans. Proc Natl Acad Sci U S A 101:1345

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  77. Kent ML, Watral V, Wu M et al (2006) In vivo and in vitro growth of Mycobacterium marinum at homoeothermic temperatures. FEMS Microbiol Lett 257:69

    Article  CAS  PubMed  Google Scholar 

  78. Boisvert H, Schreder KH (1977) Skin ulcer caused by Mycobacterium ulcerans in Cameroon. II. Bacteriologic study. Bull Soc Pathol Exot Filiales 70:125

    CAS  PubMed  Google Scholar 

  79. Fenner F (1956) The pathogenic behavior of Mycobacterium ulcerans and Mycobacterium balnei in the mouse and the developing chick embryo. Am Rev Tuberc 73:650

    CAS  PubMed  Google Scholar 

  80. Hong H, Coutanceau E, Leclerc M et al (2008) Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis 2:e325

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  81. Vandelannoote K, Durnez L, Amissah D et al (2010) Application of real-time PCR in Ghana, a Buruli ulcer-endemic country, confirms the presence of Mycobacterium ulcerans in the environment. FEMS Microbiol Lett 304:191

    Article  CAS  PubMed  Google Scholar 

  82. Eddyani M, Portaels F (2007) Survival of Mycobacterium ulcerans at 37 degrees C. Clin Microbiol Infect 13:1033

    Article  CAS  PubMed  Google Scholar 

  83. Käser M, Rondini S, Naegeli M et al (2007) Evolution of two distinct phylogenetic lineages of the emerging human pathogen Mycobacterium ulcerans. BMC Evol Biol 7:177

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  84. Yip MJ, Porter JL, Fyfe JA et al (2007) Evolution of Mycobacterium ulcerans and other mycolactone-producing mycobacteria from a common Mycobacterium marinum progenitor. J Bacteriol 189:2021

    Article  CAS  PubMed  Google Scholar 

  85. Röltgen K, Stinear TP, Pluschke G (2012) The genome, evolution and diversity of Mycobacterium ulcerans. Infect Genet Evol 12:522

    Article  PubMed  CAS  Google Scholar 

  86. Stragier P, Ablordey A, Bayonne LM et al (2006) Heterogeneity among Mycobacterium ulcerans isolates from Africa. Emerg Infect Dis 12:844

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  87. Doig KD, Holt KE, Fyfe JA et al (2012) On the origin of Mycobacterium ulcerans, the causative agent of Buruli ulcer. BMC Genomics 13:258

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  88. George KM, Chatterjee D, Gunawardana G et al (1999) Mycolactone: a polyketide toxin from Mycobacterium ulcerans required for virulence. Science 283:854

    Article  CAS  PubMed  Google Scholar 

  89. Gunawardana G, Chatterjee D, George KM et al (1999) Mycolactone A and B: toxins of Mycobacterium ulcerans. J Am Chem Soc 121:6092

    Article  CAS  Google Scholar 

  90. Ross BC, Marino L, Oppedisano F et al (1997) Development of a PCR assay for rapid diagnosis of Mycobacterium ulcerans infection. J Clin Microbiol 35:1696

    CAS  PubMed Central  PubMed  Google Scholar 

  91. Portaels F, Chemlal K, Elsen P et al (2001) Mycobacterium ulcerans in wild animals. Rev Sci Tech Off Int Epiz 20:252

    Article  CAS  Google Scholar 

  92. Johnson PD, Azuolas J, Lavender CJ et al (2007) Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis 13:1653

    Article  PubMed Central  PubMed  Google Scholar 

  93. Fyfe JA, Lavender CJ, Johnson PD et al (2007) Development and application of two multiplex real-time PCR assays for the detection of Mycobacterium ulcerans in clinical and environmental samples. Appl Environ Microbiol 73:4733

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  94. Portaels F, Meyers WM, Ablordey A et al (2008) First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis 2:e178

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  95. Williamson HR, Benbow ME, Nyuyen KD et al (2008) Distribution of Mycobacterium ulcerans in Buruli ulcer endemic and non-endemi aquatic sites in Ghana. PLoS Negl Trop Dis 2:e205

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  96. Benbow ME, Williamson H, Kimbirauskas R et al (2008) Aquatic invertebrates as unlikely vectors of Buruli ulcer disease. Emerg Infect Dis 14:1247

    Article  PubMed Central  PubMed  Google Scholar 

  97. Aiga H, Amano T, Cairncross S et al (2004) Assessing water-related risk factors for Buruli ulcer: a case-control study in Ghana. Am J Trop Med Hyg 71:387

    PubMed  Google Scholar 

  98. Raghunathan PL, Whitney EA, Asamoa K et al (2005) Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case-control study in Ghana. Clin Infect Dis 40:1445

    Article  PubMed  Google Scholar 

  99. Meyers WM, Tignokpa N, Priuli GB et al (1996) Mycobacterium ulcerans infection (Buruli ulcer): first reported patients in Togo. Br J Dermatol 134:1116

    Article  CAS  PubMed  Google Scholar 

  100. Merrit RW, Benbow ME, Small PCL (2005) Unraveling an emerging disease associated with disturbed aquatic environments: the case of Buruli ulcer. Front Ecol Environ 3:323

    Article  Google Scholar 

  101. Wagner T, Benbow ME, Brenden T et al (2008) Buruli ulcer disease prevalence in Benin, West Africa: association with land use/cover and the identification of disease clusters. Int J Health Geogr 7:25

    Article  PubMed Central  PubMed  Google Scholar 

  102. Duker AA, Portaels F, Hale M (2006) Pathway of Mycobacterium ulcerans infection: a review. Environ Int 32:567

    Article  PubMed  Google Scholar 

  103. Kibadi K, Panda M, Tamfum JJ et al (2008) New foci of Buruli ulcer, Angola and Democratic Republic of Congo. Emerg Infect Dis 14:1790

    Article  PubMed Central  PubMed  Google Scholar 

  104. Palomino JC, Obiang AM, Realini L et al (1998) Effect of oxygen on growth of Mycobacterium ulcerans in the BACTEC system. J Clin Microbiol 36:3420

    CAS  PubMed Central  PubMed  Google Scholar 

  105. Hayman J (1991) Postulated epidemiology of Mycobacterium ulcerans infection. Int J Epidemiol 20:1093

    Article  CAS  PubMed  Google Scholar 

  106. Jacobsen KH, Padgett JJ (2010) Risk factors for Mycobacterium ulcerans infection. Int J Infect Dis 14:e677

    Article  PubMed  Google Scholar 

  107. Duker AA, Carranza EJ, Hale M (2004) Spatial dependency of Buruli ulcer prevalence on arsenic-enriched domains in Amansie West District, Ghana: implications for arsenic mediation in Mycobacterium ulcerans infection. Int J Health Geogr 3:19

    Article  PubMed Central  PubMed  Google Scholar 

  108. Debacker M, Portaels F, Aguiar J et al (2006) Risk factors for Buruli ulcer, Benin. Emerg Infect Dis 12:1325

    Article  PubMed Central  PubMed  Google Scholar 

  109. Pouillot R, Matias G, Wondje CM et al (2007) Risk factors for Buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis 1:e101

    Article  PubMed Central  PubMed  Google Scholar 

  110. Revill WDL, Barker DJP (1972) Seasonal distribution of mycobacterial skin ulcers. Br J Prev Soc Med 26:23

    CAS  PubMed Central  PubMed  Google Scholar 

  111. Quek TY, Henry MJ, Pasco JA et al (2007) Mycobacterium ulcerans infection: factors influencing diagnostic delay. Med J Aust 187:561

    PubMed  Google Scholar 

  112. Sopoh GE, Johnson RC, Chauty A et al (2007) Buruli ulcer surveillance, Benin, 2003–2005. Emerg Infect Dis 13:1374

    Article  PubMed Central  PubMed  Google Scholar 

  113. Marion E, Eyangoh S, Yeramian E et al (2010) Seasonal and regional dynamics of M. ulcerans transmission in environmental context: deciphering the role of water bugs as hosts and vectors. PLoS Negl Trop Dis 4:e731

    Article  PubMed Central  PubMed  Google Scholar 

  114. Debacker M, Zinsou C, Aguiar J et al (2003) First case of Mycobacterium ulcerans disease (Buruli ulcer) following a human bite. Clin Infect Dis 36:e67

    Article  PubMed  Google Scholar 

  115. Marsollier L, Robert R, Aubry J et al (2002) Aquatic insects as a vector for Mycobacterium ulcerans. Appl Environ Microbiol 68:4623

    Article  PubMed Central  PubMed  Google Scholar 

  116. Marsoiller L, Legras P, Manceau AL et al (2002) Role des punaises d’eau dans la transmission de M. ulcerans. Bull ALLF 10:23

    Google Scholar 

  117. Marsoiller L, Aubry J, Saint-Andre JP et al (2003) Ecology and transmission of Mycobacterium ulcerans. Pathol Biol 51:490

    Article  Google Scholar 

  118. Marsoiller L, Aubry J, Cutanceau JP et al (2005) Colonization of the salivary glands of Naucoris cimicoides by Mycobacterium ulcerans requires host plasmocytes and a macrolide toxin, mycolactone. Cell Microbiol 7:935

    Article  CAS  Google Scholar 

  119. Mosi L, Williamson H, Wallace JR et al (2008) Persistent association of Mycobacterium ulcerans with West African predaceous insects of the family Belostomatidae. Appl Environ Microbiol 74:7036

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  120. Marsollier L, André JP, Frigui W et al (2007) Early trafficking events of Mycobacterium ulcerans within Naucoris cimicoides. Cell Microbiol 9:347

    Article  CAS  PubMed  Google Scholar 

  121. Silva MT, Portaels F, Pedrosa J (2007) Aquatic insects and Mycobacterium ulcerans: an association relevant to Buruli ulcer control? PLoS Med 4:e63

    Article  PubMed Central  PubMed  Google Scholar 

  122. Marsollier L, Sévérin T, Aubry J et al (2004) Aquatic snails, passive hosts of Mycobacterium ulcerans. Appl Environ Microbiol 70:6296

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  123. Veicht MGK, Johnson DPR, Flood P et al (1997) A large localized outbreak of Mycobcaterium ulcerans infection on a temperate southern Australian island. Epidemiol Infect 119:313

    Article  Google Scholar 

  124. Johnson PD, Veitch MG, Flood PE et al (1995) Mycobacterium ulcerans infection on Phillip Island, Victoria. Med J Aust 162:221

    CAS  PubMed  Google Scholar 

  125. Fyfe JA, Lavender CJ, Handasyde KA et al (2010) A major role for mammals in the ecology of Mycobacterium ulcerans. PLoS Negl Trop Dis 4:e791

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  126. Forbes BR, Wannan JS, Kirkland WB (1954) Indolent cutaneous ulceration due to infection with Mycobacterium ulcerans. Med J Aust 41:475

    CAS  PubMed  Google Scholar 

  127. Connor DH, Washington CM, Fletcher LH (1966) Buruli ulceration. A clinicopathologic study of 38 Ugandans with Mycobacterium ulcerans ulceration. Arch Pathol 81:183

    Google Scholar 

  128. Goto M, Nakanaga K, Aung T et al (2006) Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in Buruli ulcer. Am J Pathol 168:805

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  129. Sarfo FS, Phillips R, Wansbrough-Jones M et al (2016) Recent advances: role of mycolactone in the pathogenesis and monitoring of Mycobacterium ulcerans infection/Buruli ulcer disease. Cell Microbiol 18:17

    Article  CAS  PubMed  Google Scholar 

  130. Mve-Obiang A, Lee RE, Portaels F et al (2003) Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence. Infect Immunol 71:774

    Article  CAS  Google Scholar 

  131. Pidot SJ, Hong H, Seemann T et al (2008) Deciphering the genetic basis for polyketide variation among mycobacteria producing mycolactones. BMC Genomics 9:462

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  132. Sarfo FS, Phillips RO, Rangers B et al (2010) Detection of mycolactone A/B in Mycobacterium ulcerans-infected human tissue. PLoS Negl Trop Dis 4:e577

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  133. Sarfo FS, Phillips RO, Zhang J et al (2014) Kinetics of mycolactone in human subcutaneous tissue during antibiotic therapy for Mycobacterium ulcerans disease. BMC Infect Dis 14:202

    Google Scholar 

  134. Hong H, Coutanceau E, Leclerc M et al (2008) Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs. PLoS Negl Trop Dis 2:e325

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  135. Sarfo FS, Le Chevalier F, Aka N et al (2011) Mycolactone diffuses into the peripheral blood of Buruli ulcer patients—implications for diagnosis and disease monitoring. PLoS Negl Trop Dis 5:e1237

    Article  PubMed Central  PubMed  Google Scholar 

  136. O’Brien DP, Comte E, Serafini M et al (2014) The urgent need for clinical, diagnostic, and operational research for management of Buruli ulcer in Africa. Lancet Infect Dis 14:435

    Article  PubMed  Google Scholar 

  137. Marion E, Song OR, Christophe T et al (2014) Mycobacterial toxin induces analgesia in Buruli ulcer by targeting the angiotensin pathways. Cell 157:1565

    Article  CAS  PubMed  Google Scholar 

  138. George KM, Pascopella L, Welty DM et al (2000) A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells. Infect Immunol 68:877

    Article  CAS  Google Scholar 

  139. Coutanceau E, Decalf J, Martino A et al (2007) Selective suppression of dendritic cell functions by Mycobacterium ulcerans toxin mycolactone. J Exp Med 204:1395

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  140. Simmonds RE, Lali FV, Smallie T et al (2009) Mycolactone inhibits monocyte cytokine production by a posttranscriptional mechanism. J Immunol 182:2194

    Article  CAS  PubMed  Google Scholar 

  141. Boulkroun S, Guenin-Macé L, Thoulouze MI et al (2010) Mycolactone suppresses T cell responsiveness by altering both early signaling and posttranslational events. J Immunol 184:1436

    Article  CAS  PubMed  Google Scholar 

  142. Adusumilli S, Mve-Obiang A, Sparer T et al (2005) Mycobacterium ulcerans toxic macrolide, mycolactone, modulates the host immune response and cellular location of M. ulcerans in vitro and in vivo. Cell Microbiol 7:1295

    Article  CAS  PubMed  Google Scholar 

  143. Schütte D, Um-Boock A, Mensah-Quainoo E et al (2007) Development of highly organized lymphoid structures in Buruli ulcer lesions after treatment with rifampicin and streptomycin. PLoS Negl Trop Dis 1:e2

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  144. Hall B, Simmonds R (2014) Pleiotropic molecular effects of the Mycobacterium ulcerans virulence factor mycolactone underlying the cell death and immunosuppression seen in Buruli ulcer. Biochem Soc Trans 42:177

    Article  CAS  PubMed  Google Scholar 

  145. Vincent QB, Ardant MF, Adeye A et al (2014) Clinical epidemiology of laboratory-confirmed Buruli ulcer in Benin: a cohort study. Lancet Glob Health 2:e422

    Article  PubMed  Google Scholar 

  146. Amofah G, Bonsu F, Tetteh C et al (2002) Buruli ulcer in Ghana: results of a national case search. Emerg Infect Dis 8:167

    Article  PubMed Central  PubMed  Google Scholar 

  147. Boyd SC, Athan E, Friedman ND et al (2012) Epidemiology, clinical features and diagnosis of Mycobacterium ulcerans in an Australian population. Med J Aust 196:341

    Article  PubMed  Google Scholar 

  148. O’Brien DP, Friedman ND, Cowan R et al (2015) Mycobacterium ulcerans in the elderly: more severe disease and suboptimal outcomes. PLoS Negl Trop Dis 9:e0004253

    Article  PubMed Central  PubMed  Google Scholar 

  149. Eddyani M, Debacker M, Martin A et al (2008) Primary culture of Mycobacterium ulcerans from human tissue specimens after storage in semisolid transport medium. J Clin Microbiol 46:69

    Article  PubMed  Google Scholar 

  150. Bratschi MW, Bolz M, Grize L et al (2014) Primary cultivation: factors affecting contamination and Mycobacterium ulcerans growth after long turnover time of clinical specimens. BMC Infect Dis 14:636

    Article  PubMed Central  PubMed  Google Scholar 

  151. Converse PJ, Xing Y, Kim KH et al (2014) Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease. PLoS Negl Trop Dis 8:e2618

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  152. Affolabi D, Bankole H, Ablordey A et al (2008) Effects of grinding surgical tissue specimens and smear staining methods on Buruli ulcer microscopic diagnosis. Tropical Med Int Health 13:187

    Article  Google Scholar 

  153. Herbinger KH, Adjei O, Awua-Boateng NY et al (2009) Comparative study of the sensitivity of different diagnostic methods for the laboratory diagnosis of Buruli ulcer disease. Clin Infect Dis 48:1055

    Article  PubMed  Google Scholar 

  154. Phillips RO, Sarfo FS, Osei-Sarpong F et al (2009) Sensitivity of PCR targeting Mycobacterium ulcerans by use of fine-needle aspirates for diagnosis of Buruli ulcer. J Clin Microbiol 47:924

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  155. Portaels F (ed) (2014) Laboratory diagnosis of Buruli ulcer: a mammal for health care providers. World Health Organization, Geneva

    Google Scholar 

  156. Lavender CJ, Fyfe JA (2013) Direct detection of Mycobacterium ulcerans in clinical specimens and environmental samples. Methods Mol Biol 943:201

    Article  CAS  PubMed  Google Scholar 

  157. Mitjà O, Lukehart SA, Pokowas G et al (2014) Haemophilus ducreyi as a cause of skin ulcers in children from a yaws-endemic area of Papua New Guinea: a prospective cohort study. Lancet Glob Health 2:e235

    Article  PubMed  Google Scholar 

  158. Lindo SD, Daniels F Jr (1974) Buruli ulcer in New York City. JAMA 228:1138

    Article  CAS  PubMed  Google Scholar 

  159. Faber WR, de Jong B, de Vries HJ et al (2015) Buruli ulcer in traveler from Suriname, South America, to the Netherlands. Emerg Infect Dis 21:497

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  160. Phillips R, Horsfield C, Kujper S et al (2005) Sensitivity of PCR targeting the IS2404 insertion sequence of Mycobacterium ulcerans in an assay using punch biopsy specimens for diagnosis of Buruli ulcer. J Clin Microbiol 43:3650

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  161. Johnson RC, Nackers F, Glynn JR et al (2008) Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS 22:901

    Article  PubMed  Google Scholar 

  162. Portaels F, Zinson C, Aguiar J et al (2003) Les atteintes osseuses dans l’ulcère de Buruli: à propos de 73 cas. Bull Séanc Acad R Sci Outre-Mer 49:161

    Google Scholar 

  163. Phillips R, Sarfo FS, Guenin-Macé L et al (2009) Immunosuppressive signature of cutaneous Mycobacterium ulcerans infection in the peripheral blood of patients with Buruli ulcer disease. J Infect Dis 200:1675

    Article  CAS  PubMed  Google Scholar 

  164. Bahebeck J, Bedimo R, Eyenga V et al (2004) The management of musculoskeletal infection in HIV carriers. Acta Orthop Belg 70:355

    PubMed  Google Scholar 

  165. Toll A, Gallardo F, Ferran M et al (2005) Aggressive multifocal Buruli ulcer with associated osteomyelitis in an HIV-positive patient. Clin Exp Dermatol 30:649

    Article  CAS  PubMed  Google Scholar 

  166. Christinet V, Comte E, Ciaffi L et al (2014) Impact of human immunodeficiency virus on the severity of Buruli ulcer disease: results of a retrospective study in Cameroon. Open Forum Infect Dis 1:ofu021

    Article  PubMed Central  PubMed  Google Scholar 

  167. World Health Organization (2004) Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). WHO.CDS/CPE&GB11.10

    Google Scholar 

  168. Klis S, Stienstra Y, Phillips RO et al (2014) Long term streptomycin toxicity in the treatment of Buruli ulcer: follow-up of participants in the BURULICO drug trial. PLoS Negl Trop Dis 8:e2739

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  169. O’Brien DP, Jenkin G, Buntine J et al (2014) Treatment and prevention of Mycobacterium ulcerans infection (Buruli ulcer) in Australia: guideline update. Med J Aust 200:267

    Article  PubMed  Google Scholar 

  170. Sugawara M, Ishii N, Nakanaga K et al (2015) Exploration of a standard treatment for Buruli ulcer through a comprehensive analysis of all cases diagnosed in Japan. J Dermatol 42:588

    Article  CAS  PubMed  Google Scholar 

  171. Phillips R, Kuijper S, Benjamin N et al (2004) In vitro killing of Mycobacterium ulcerans by acidified nitrite. Antimicrob Agents Chemother 48:3130

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  172. Phillips R, Adjei O, Lucas S et al (2004) Pilot randomized double-blind trial of treatment of Mycobacterium ulcerans disease (Buruli ulcer) with topical nitrogen oxides. Antimicrob Agents Chemother 48:2866

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  173. Adjei O, Evans MR, Asiedu A (1998) Phenytoin in the treatment of Buruli ulcer. Trans R Soc Trop Med Hyg 92:108

    Article  CAS  PubMed  Google Scholar 

  174. World Health Organization (2012) Treatment of Mycobacterium ulcerans disease (Buruli ulcer). World Health Organization, Geneva

    Google Scholar 

  175. Ruf MT, Chauty A, Adeye A et al (2011) Secondary Buruli ulcer skin lesions emerging several months after completion of chemotherapy: paradoxical reaction or evidence for immune protection? PLoS Negl Trop Dis 5:e1252

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  176. Nienhuis WA, Stienstra Y, Abass KM et al (2012) Paradoxical responses after start of antimicrobial treatment in Mycobacterium ulcerans infection. Clin Infect Dis 54:519

    Article  PubMed  Google Scholar 

  177. Sambourg E, Dufour J, Edouard S et al (2014) Paradoxical reactions and responses during antibiotic treatment for Mycobacterium ulcerans infection (Buruli ulcer). Four cases from French Guiana. Ann Dermatol Venereol 141:413

    Article  CAS  PubMed  Google Scholar 

  178. Asiedu K, Raviglione MC, Scherphier R (2000) World Health Organization. Global Buruli ulcer iniziative. Buruli ulcer: Mycobacterium ulcerans infection. World Health Organization, Geneva

    Google Scholar 

  179. Meyers WM, Shelly WM, Connor DH (1974) Heat treatment of Mycobacterium ulcerans infections without surgical excision. Am J Trop Med Hyg 23:924

    Article  CAS  PubMed  Google Scholar 

  180. Junghanss T, Um Boock A, Vogel M et al (2009) Phase change material for thermotherapy of Buruli ulcer: a prospective observational single centre proof-of-principle trial. PLoS Negl Trop Dis 3:e380

    Article  PubMed Central  PubMed  Google Scholar 

  181. Braxmeier S, Hellmann M, Beck A et al (2009) Phase change material for thermotherapy of Buruli ulcer: modelling as an aid to implementation. J Med Eng Technol 33:559

    Article  CAS  PubMed  Google Scholar 

  182. Vogel M, Bayi PF, Ruf MT et al (2016) Local heat application for the treatment of Buruli ulcer: results of a phase II open label single center non comparative clinical trial. Clin Infect Dis 62:342

    Article  PubMed  Google Scholar 

  183. Smith PG, Revill WD, Lukwago E et al (1976) The protective effect of BCG against Mycobacterium ulcerans disease: a controlled trial in an endemic area of Uganda. Trans R Soc Trop Med Hyg 70:449

    Article  CAS  PubMed  Google Scholar 

  184. Portaels F, Aguiar J, Debacker M et al (2002) Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol 9:1389

    CAS  PubMed Central  PubMed  Google Scholar 

  185. Nackers F, Dramaix M, Johnson RC et al (2006) BCG vaccine effectiveness against Buruli ulcer: a case-control study in Benin. Am J Trop Med Hyg 75:768

    PubMed  Google Scholar 

  186. Tanghe A, Adnet PY, Gartner T et al (2007) A booster vaccination with Mycobacterium bovis BCG does not increase the protective effect of the vaccine against experimental Mycobacterium ulcerans infection in mice. Infect Immunol 75:2642

    Article  CAS  Google Scholar 

  187. Hart BE, Hale LP, Lee S (2015) Recombinant BCG expressing Mycobacterium ulcerans Ag85A imparts enhanced protection against experimental Buruli ulcer. PLoS Negl Trop Dis 9:e0004046

    Article  PubMed Central  PubMed  Google Scholar 

  188. Phillips RO, Phanzu DM, Beissner M et al (2015) Effectiveness of routine BCG vaccination on Buruli ulcer disease: a case-control study in the Democratic Republic of Congo, Ghana and Togo. PLoS Negl Trop Dis 9:e3457

    Article  PubMed Central  PubMed  Google Scholar 

  189. Pedrique B, Strub-Wourgaft N, Some C et al (2013) The drug and vaccine landscape for neglected diseases (2000–11): a systematic assessment. Lancet Glob Health 1:e371

    Article  PubMed  Google Scholar 

  190. O’Brien DP, Ford N, Vitoria M et al (2015) Generating evidence to improve the response to neglected diseases: how operational research in a Médecins Sans Frontières Buruli ulcer treatment programme informed international management guidance. PLoS Negl Trop Dis 9:e0004075

    Article  PubMed Central  PubMed  Google Scholar 

  191. Wadagni A, Frimpong M, Phanzu DM et al (2015) Simple, rapid Mycobacterium ulcerans disease diagnosis from clinical samples by fluorescence of mycolactone on thin layer chromatography. PLoS Negl Trop Dis 9:e0004247

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Biomedical Science and Human Oncology, University of Bari “Aldo Moro”, Bari, Italy

    Domenico Bonamonte MD, PhD

  2. University of Bari “Aldo Moro”, Bari, Italy

    Angela Filoni MD & Gianni Angelini MD (Professor of Dermatology, Former Professor and Chairman)

Authors
  1. Domenico Bonamonte MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Angela Filoni MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Gianni Angelini MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Domenico Bonamonte MD, PhD .

Editor information

Editors and Affiliations

  1. University of Bari “Aldo Moro”, Department of Biomedical Science and Human Oncology, Bari, Italy

    Domenico Bonamonte

  2. University of Bari “Aldo Moro”, Dermatology, Bari, Italy

    Gianni Angelini

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Bonamonte, D., Filoni, A., Angelini, G. (2017). Mycobacterium ulcerans Infection. In: Bonamonte, D., Angelini, G. (eds) Mycobacterial Skin Infections. Springer, Cham. https://doi.org/10.1007/978-3-319-48538-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-48538-6_10

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-48537-9

  • Online ISBN: 978-3-319-48538-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation